Reference Pricing

Home » Reference Pricing

Single Exit Price

The Single Exit Price regulations, which came into effect in 2005 and govern the pricing of prescribed medicines (Schedules 1-7 drugs), have had a massive impact on the medical scheme industry.

What is reference pricing?

The reference price is a limit to the financial benefit available for your medication (drug). If the cost of the drug that you are using is greater than the applicable reference price, then you will be required to pay the difference between the cost of your drug and the reference price at the point of sale.

Profmed applies a generic reference pricing model to acute medicines, and both generic and therapeutic reference pricing to medicines used in the management of chronic conditions.

What is the difference between generic and therapeutic reference pricing?

    • The Single Exit Price regulations,  came into effect in 2005 and govern the pricing of prescribed medicines (Schedules 1-7 drugs) have had a massive impact on the medical scheme industry.

      Refer to the MediKredit website at www.medikredit.net for a list of the categories to which MMAP® applies and the limits applicable.

    • What is a “generic” drug?

    • A generic drug is a copy of the original drug that may be sold once a company’s patent on a brand-name drug has expired. Generic drugs have the same active ingredient(s), strength and dosage form as the original drug. Generic drugs are typically cheaper than the original or brand-name drug as they don’t carry the research and development costs that are incurred by the originating company. Furthermore, raw materials become more widely available on world markets. Generic pharmaceutical companies compete with each other, thus driving down the cost of medicines.

    • Do brand-name drugs work more effectively than generic drugs? Are generic drugs safe?
    • Generic drugs may have a different name and look or taste different because of the choice of the inactive ingredients, such as colouring, binding and flavouring. By law, the active ingredient(s) in the generic and brand-name products must be exactly the same.

      The drug regulatory authority of each country, in the case of South Africa the Medicines Control Council (MCC), has strict criteria that must be applied before a generic drug is registered. No drugs may be sold without this approval. All pharmaceutical manufacturers must comply with ‘Good Manufacturing Practices’ as prescribed by the MCC and they are regularly inspected.

      All generic products are, however, not interchangeable with brand-name products. The MCC has drawn up a specific list of
      “Non-substitutable Medicines” that should not be interchanged. These are excluded from MMAP®  consideration.

    • When should you use a generic drug?
    • In May 2003, the law changed regarding substitution of an original drug with a generic equivalent. By law, your pharmacist should advise you on the availability and benefits of a generic equivalent drug. He or she should dispense a generic equivalent drug unless:

      • your doctor has specifically forbidden substitution of the prescribed medication with a generic equivalent
      • the generic equivalent is more expensive than the prescribed medication
      • the product has been declared non-substitutable by the MCC
      • you, as the patient, decline the use of a generic product after being briefed by the pharmacist. This, however, could result in you having to pay a co-payment.

    • Why should use a generic vs a branded product?
    • Generic substitution can reduce the price of your medication and assist you in managing your medication benefit to ensure that you maximise the value of your medical scheme benefits. This helps to contain total medicine expenditure, which in turn limits annual contribution increases.

      • Profmed applies therapeutic reference pricing to all registered chronic conditions, therefore if you or one of your dependants are registered with a chronic condition, you will be affected by reference pricing limits. A therapeutic reference price applies to drugs that fall in the same drug class or have a similar action on the body, and is not limited to drugs with generic equivalents.

      • Is the limit the same across all options?
      • The therapeutic reference price will differ from one option to another. For example, the reference price for ProPinnacle will be higher than that for ProActive. Therefore, your co-payment due to reference pricing may be lower or even not applicable if you are a member of ProPinnacle compared to ProActive. The reference price is determined and maintained by a team of clinical experts who monitor changes in therapy and apply cost-effective medicine management. It is important to note that there are always drugs available that are below the reference price for a therapeutic class (drugs with similar ingredients).

        • The first step is to always ask your pharmacist or healthcare provider for a generic alternative. This is the same ingredient, strength and dosage form as the original product but manufactured or marketed by a different manufacturer. This will in many cases result in no co-payment or reduce any potential co-payments by you.

          Secondly, if you prefer not to pay a co-payment then your doctor can advise you what your therapeutic alternatives are that will be below the reference price. Your doctor can contact Swift Online on 0800 132 345 to discuss possible alternatives with the clinical consultant, and will need to supply you with an amended prescription if he/she agrees to change your medication to a drug that is below the reference price. To assist you in making an informed decision regarding the product you wish to use and to avoid a co-payment, you may consult the Generic/ Therapeutic medication search functionality by visiting the website at www.medikredit.net.

            1. Choose an option appropriate to the level of cover you require
            2. Always request a generic alternative, if available
            3. If a co-payment is still applicable, this is because there are more cost-effective therapies available on your chosen option, and your healthcare provider will need to contact Swift Online on 0800 132 345 to discuss alternatives
            4. If you change to an alternative drug, obtain a new script from your doctor to avoid a reference price co-payment.